- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 5/10 - Tétrapeptides
Détention brevets de la classe C07K 5/10
Brevets de cette classe: 737
Historique des publications depuis 10 ans
|
67
|
56
|
66
|
60
|
64
|
52
|
32
|
22
|
27
|
12
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| ISP Investments Inc. | 441 |
17 |
| The University of British Columbia | 1546 |
13 |
| Stealth Biotherapeutics Corp | 36 |
11 |
| Stealth Biotherapeutics Inc. | 194 |
11 |
| Bristol-myers Squibb Company | 4748 |
9 |
| S.i.s. Shulov Innovative Science Ltd. | 17 |
8 |
| Endocyte, Inc. | 115 |
7 |
| Helix Biomedix Inc. | 30 |
7 |
| Lipotec, S.A. | 208 |
7 |
| The Regents of the University of California | 20802 |
6 |
| Mimetogen Pharmaceuticals, Inc. | 17 |
6 |
| Onyx Therapeutics, Inc. | 66 |
6 |
| Daiichi Sankyo Company, Limited | 1891 |
5 |
| Mederis Diabetes, LLC | 23 |
5 |
| Sekisui Chemical Co., Ltd. | 3626 |
5 |
| Zedira GmbH | 38 |
5 |
| Lactocore, Inc. | 6 |
5 |
| Centre National de La Recherche Scientifique | 11055 |
4 |
| California Institute of Technology | 4038 |
4 |
| Agency for Science, Technology and Research | 3744 |
4 |
| Autres propriétaires | 592 |